Visicell Medical Inc. had successfully closed the oversubscribed $1 million dollars convertible note offering led by industry expert Life...

Visicell is proud to announce the newest addition to our stellar executive team. After retiring in May of 2019 from the Canary Center at...

After completing a highly competitive and selective admission process, Visicell and its co-founders had been invited to join the...

Visicell is presenting at Alliance for Regenerative Medicine’s Cell & Gene Meeting on the Mesa! Taking place October 12-16, this virtual...

We saw lots of action in the biopharma merger and acquisition (M&A) space in 2019, headlined by Bristol-Myers Squibb acquiring Celgene...

We proudly introduce the newest addition to the Visicell family, the Visicell Board of Advisors: George Smith, PhD, MBA Director, Cell &...